Skip to main content
Erschienen in: Pediatric Nephrology 5/2005

01.05.2005 | Original Article

Renal involvement in Down syndrome

verfasst von: Serafín Málaga, Rafael Pardo, Ignacio Málaga, Gonzalo Orejas, Joaquín Fernández-Toral

Erschienen in: Pediatric Nephrology | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Kidney disease has not been considered a frequent complication in Down syndrome (DS) patients; a variety of urological abnormalities and glomerulopathies have been reported in this population, and some DS patients develop chronic renal failure (CRF).The aim of this study was to improve the understanding of renal disease in patients with DS, focusing on the incidence and range of kidney and urological abnormalities in a population of DS patients. A cross-sectional study was carried out in DS patients referred from a pediatric genetics unit of a tertiary care center. Medical records were reviewed. A 24-h urine specimen and a blood sample were obtained. Fractional excretion of sodium and potassium, tubular reabsorption of phosphate, urinary excretion of calcium, magnesium, uric acid, creatinine clearance and proteinuria were determined. Ultrasound was performed to evaluate the kidneys and the urinary tract. Laboratory data were reviewed for any possible renal disorder. Sixty-nine patients, aged 12 months to 24 years, were recruited. Pathological findings included three cases of voiding disturbances and a case of hypertension in a 7-year old girl. Eight patients (11.6%) had hyperuricemia without gout. Eighteen patients (24.2%) had hyperuricosuria. Urinalysis revealed three cases of mild proteinuria and two patients with microscopic hematuria. Minor radiological abnormalities were found in five patients (7.3%). Three patients (4.5%) had CRF. Renal disease in patients with DS is not as rare as previously thought, although the majority of findings are of minor relevance. According to the variety of pathologies, and in order to detect early irreversible renal injury, it seems quite reasonable to perform regular monitoring of renal function in these patients.
Literatur
1.
Zurück zum Zitat Baird PA, Sadovnick AD (1989) Life tables for Down syndrome. Hum Genet 82:291–294 Baird PA, Sadovnick AD (1989) Life tables for Down syndrome. Hum Genet 82:291–294
2.
Zurück zum Zitat Berg JM, Crome L, France NE (1960) Congenital cardiac malformations in mongolism. Br Heart J 22:331–346 Berg JM, Crome L, France NE (1960) Congenital cardiac malformations in mongolism. Br Heart J 22:331–346
3.
Zurück zum Zitat Ahmed S (1990) Vesico-ureteric reflux in Down syndrome: poor prognosis. Aust NZ J Surg 60:113–116 Ahmed S (1990) Vesico-ureteric reflux in Down syndrome: poor prognosis. Aust NZ J Surg 60:113–116
4.
Zurück zum Zitat Ariel I, Wells TR, Landing BH, Singer DB (1991) The urinary system in Down syndrome: a study of 124 autopsy cases. Pediatr Pathol 11:879–888 Ariel I, Wells TR, Landing BH, Singer DB (1991) The urinary system in Down syndrome: a study of 124 autopsy cases. Pediatr Pathol 11:879–888
5.
Zurück zum Zitat Kupferman JC, Stewart CL, Kaskel FJ, Fine RN (1996) Posterior urethral valves in patients with Down syndrome. Pediatr Nephrol 10:143–146 Kupferman JC, Stewart CL, Kaskel FJ, Fine RN (1996) Posterior urethral valves in patients with Down syndrome. Pediatr Nephrol 10:143–146
6.
Zurück zum Zitat Gupta SK, Venkataseshan VS, Churg J (1991) Mesangiocapillary glomerulonephritis in Down syndrome. Am J Nephrol 11:112–117 Gupta SK, Venkataseshan VS, Churg J (1991) Mesangiocapillary glomerulonephritis in Down syndrome. Am J Nephrol 11:112–117
7.
Zurück zum Zitat Takemura T, Yoshioka K, Akano N, Michihata I, Okada M, Maki S (1993) Immunotactoid glomerulopathy in a child with Down syndrome. Pediatr Nephrol 7:86–88 Takemura T, Yoshioka K, Akano N, Michihata I, Okada M, Maki S (1993) Immunotactoid glomerulopathy in a child with Down syndrome. Pediatr Nephrol 7:86–88
8.
Zurück zum Zitat Proesmans W (1996) Hypercalcaemia, hypercalciuria and nephrocalcinosis in Down syndrome. Pediatr Nephrol 10:543–544 Proesmans W (1996) Hypercalcaemia, hypercalciuria and nephrocalcinosis in Down syndrome. Pediatr Nephrol 10:543–544
9.
Zurück zum Zitat Kupferman JC, Stewart CL, Kaskel FJ, Katz SP, Fine RN (1994) Chronic peritoneal dialysis in a child with Down syndrome. Pediatr Nephrol 8:644–645 Kupferman JC, Stewart CL, Kaskel FJ, Katz SP, Fine RN (1994) Chronic peritoneal dialysis in a child with Down syndrome. Pediatr Nephrol 8:644–645
10.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1997 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1997 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program
11.
Zurück zum Zitat Schwartz GJ, Haycock GB, Edelmann CM, Jr., Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed Schwartz GJ, Haycock GB, Edelmann CM, Jr., Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed
12.
Zurück zum Zitat Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMed Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMed
13.
Zurück zum Zitat Santos F, García Nieto V (2000) Exploración basal de la función renal. In: Santos F, Garcia Nieto V (eds) Nefrologia pediatrica. Grupo Aula Medica SA, Madrid, pp 3–14 Santos F, García Nieto V (2000) Exploración basal de la función renal. In: Santos F, Garcia Nieto V (eds) Nefrologia pediatrica. Grupo Aula Medica SA, Madrid, pp 3–14
14.
Zurück zum Zitat Subrahmanyam AB, Mehta AV (1995) Renal anomalies in Down syndrome. Pediatr Nephrol 9:253–254 Subrahmanyam AB, Mehta AV (1995) Renal anomalies in Down syndrome. Pediatr Nephrol 9:253–254
15.
Zurück zum Zitat Mercer ES, Broecker B, Smith EA, Kirsch AJ, Scherz HC, Massad A (2004) Urological manifestations of Down syndrome. J Urol 171:1250–1253 Mercer ES, Broecker B, Smith EA, Kirsch AJ, Scherz HC, Massad A (2004) Urological manifestations of Down syndrome. J Urol 171:1250–1253
16.
Zurück zum Zitat Benacerraf BR, Mandell J, Estroff JA, Harlow BL, Frigoletto FD Jr (1990) Fetal pyelectasis: a possible association with Down syndrome. Obstet Gynecol 76:58–60 Benacerraf BR, Mandell J, Estroff JA, Harlow BL, Frigoletto FD Jr (1990) Fetal pyelectasis: a possible association with Down syndrome. Obstet Gynecol 76:58–60
17.
Zurück zum Zitat Seeds JW (1998) Borderline genitourinary tract abnormalities. Semin Ultrasound CT MR 19:347–354 Seeds JW (1998) Borderline genitourinary tract abnormalities. Semin Ultrasound CT MR 19:347–354
18.
Zurück zum Zitat Gilbert EF, Opitz JM (1988) Developmental and other pathologic changes in syndromes caused by chromosomal abnormalities. Perspect Pediatr Pathol 7:1–63 Gilbert EF, Opitz JM (1988) Developmental and other pathologic changes in syndromes caused by chromosomal abnormalities. Perspect Pediatr Pathol 7:1–63
19.
Zurück zum Zitat Lo A, Brown HG, Fivush BA, Neu AM, Racusen LC (1998) Renal disease in Down syndrome: autopsy study with emphasis on glomerular lesions. Am J Kidney Dis 31:329–335 Lo A, Brown HG, Fivush BA, Neu AM, Racusen LC (1998) Renal disease in Down syndrome: autopsy study with emphasis on glomerular lesions. Am J Kidney Dis 31:329–335
20.
Zurück zum Zitat Husby G, Sletten K (1986) Amiloid proteins. In: Marrink J, van Rijswijk MH (eds) Amyloidosis. Nijhoff, Dordrecht pp 23–24 Husby G, Sletten K (1986) Amiloid proteins. In: Marrink J, van Rijswijk MH (eds) Amyloidosis. Nijhoff, Dordrecht pp 23–24
21.
Zurück zum Zitat Birk PE, Burke BA, Vernier RL (1996) Glomerulonephritis in children with Down syndrome. Pediatr Nephrol 10:549 Birk PE, Burke BA, Vernier RL (1996) Glomerulonephritis in children with Down syndrome. Pediatr Nephrol 10:549
22.
Zurück zum Zitat Robson WL, Leung AK, Woodman RC, Trevenen CL (1995) Anti-neutrophil cytoplasmic antibody associated glomerulonephritis in a patient with Down’s syndrome. Pediatr Nephrol 9:204–205 Robson WL, Leung AK, Woodman RC, Trevenen CL (1995) Anti-neutrophil cytoplasmic antibody associated glomerulonephritis in a patient with Down’s syndrome. Pediatr Nephrol 9:204–205
23.
Zurück zum Zitat Schwab M, Boswald M, Ludwig K, Wittekind C, Waldherr R, Ruder H (1996) A patient with Down’s syndrome and anti-neutrophilic cytoplasmic antibody-positive vasculitis. Pediatr Nephrol 10:249–250 Schwab M, Boswald M, Ludwig K, Wittekind C, Waldherr R, Ruder H (1996) A patient with Down’s syndrome and anti-neutrophilic cytoplasmic antibody-positive vasculitis. Pediatr Nephrol 10:249–250
24.
Zurück zum Zitat Andreoli SP, Revkees S, Bull M (1995) Hypercalcemia, hypercalciuria, medullar nephrocalcinosis, and renal insufficiency in a toddler with Down syndrome. Pediatr Nephrol 9:673 Andreoli SP, Revkees S, Bull M (1995) Hypercalcemia, hypercalciuria, medullar nephrocalcinosis, and renal insufficiency in a toddler with Down syndrome. Pediatr Nephrol 9:673
25.
Zurück zum Zitat Cobenas C, Spizzirri F, Zanetta D (1998) Another toddler with Down syndrome, nephrocalcinosis, hypercalcemia, and hypercalciuria. Pediatr Nephrol 12:432 Cobenas C, Spizzirri F, Zanetta D (1998) Another toddler with Down syndrome, nephrocalcinosis, hypercalcemia, and hypercalciuria. Pediatr Nephrol 12:432
26.
Zurück zum Zitat Coburn SP, Seidenberg M, Mertz EF (1967) Clearance of uric acid, urea and creatinine in Down syndrome. J Appl Physiol 23:579–580 Coburn SP, Seidenberg M, Mertz EF (1967) Clearance of uric acid, urea and creatinine in Down syndrome. J Appl Physiol 23:579–580
27.
Zurück zum Zitat Nishida Y, Akaoka I, Kobayashi M, Maruki K, Oshima Y (1979) Renal impairment in urate excretion in patients with Down’s syndrome. J Rheumatol 6:103–107 Nishida Y, Akaoka I, Kobayashi M, Maruki K, Oshima Y (1979) Renal impairment in urate excretion in patients with Down’s syndrome. J Rheumatol 6:103–107
28.
Zurück zum Zitat Nishida Y, Akaoka I, Nishizawa T, Maruki M, Aikawa T, Mitamura T, Yokohari R, Horiuchi I (1976) A case of gouty arthritis associated with Down’s syndrome. J Ment Defic Res 20:277–283 Nishida Y, Akaoka I, Nishizawa T, Maruki M, Aikawa T, Mitamura T, Yokohari R, Horiuchi I (1976) A case of gouty arthritis associated with Down’s syndrome. J Ment Defic Res 20:277–283
29.
Zurück zum Zitat Ciompi ML, Bazzichi LM, Bertolucci MR, Mazzoni MR, Barbieri P, Mencacci S, Machia D, Mariani G (1984) Uric acid metabolism in two patients with coexisten Down syndrome and gout. Clin Rheumatol 3:229–233 Ciompi ML, Bazzichi LM, Bertolucci MR, Mazzoni MR, Barbieri P, Mencacci S, Machia D, Mariani G (1984) Uric acid metabolism in two patients with coexisten Down syndrome and gout. Clin Rheumatol 3:229–233
30.
Zurück zum Zitat Windham GC, Bjerkedal T, Langmark F (1985) A population-based study of cancer incidence in twins and in children with congenital malformations or low birth weight, Norway 1967–1980. Am J Epidemiol 121:49–56 Windham GC, Bjerkedal T, Langmark F (1985) A population-based study of cancer incidence in twins and in children with congenital malformations or low birth weight, Norway 1967–1980. Am J Epidemiol 121:49–56
31.
Zurück zum Zitat Fabia J, Drolette M (1970) Malformations and leukemia in children with Down’s syndrome. Pediatrics 45:60–70 Fabia J, Drolette M (1970) Malformations and leukemia in children with Down’s syndrome. Pediatrics 45:60–70
32.
Zurück zum Zitat Kusumakumary P, Ninan M, Chellam VG, Jacob R, Nair MK (1995) Wilm’s tumor in a child with Down syndrome. J Pediatr Hematol Oncol 17:276 Kusumakumary P, Ninan M, Chellam VG, Jacob R, Nair MK (1995) Wilm’s tumor in a child with Down syndrome. J Pediatr Hematol Oncol 17:276
33.
Zurück zum Zitat Saleun JP, Balouet G, Castel Y (1975) A case with transient leukoblastosis and renal dysembrioplasia. Nouv Presse Med 18:191 Saleun JP, Balouet G, Castel Y (1975) A case with transient leukoblastosis and renal dysembrioplasia. Nouv Presse Med 18:191
34.
Zurück zum Zitat Baqi N, Tejani A, Sullivan EK (1998) Renal transplantation in Down syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2:211–215 Baqi N, Tejani A, Sullivan EK (1998) Renal transplantation in Down syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2:211–215
35.
Zurück zum Zitat Hausmann MJ, Landau D (2002) A Down syndrome patient treated by peritoneal dialysis. Nephron 92:484–486 Hausmann MJ, Landau D (2002) A Down syndrome patient treated by peritoneal dialysis. Nephron 92:484–486
36.
Zurück zum Zitat Riano I, Malaga S, Callis L, Loris C, Martin-Govante JM, Navarro M, Vallo A (2000) Towards guidelines for dialysis in children with end-stage renal disease. Pediatr Nephrol 15:157–162 Riano I, Malaga S, Callis L, Loris C, Martin-Govante JM, Navarro M, Vallo A (2000) Towards guidelines for dialysis in children with end-stage renal disease. Pediatr Nephrol 15:157–162
Metadaten
Titel
Renal involvement in Down syndrome
verfasst von
Serafín Málaga
Rafael Pardo
Ignacio Málaga
Gonzalo Orejas
Joaquín Fernández-Toral
Publikationsdatum
01.05.2005
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 5/2005
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-005-1825-9

Weitere Artikel der Ausgabe 5/2005

Pediatric Nephrology 5/2005 Zur Ausgabe

Announcements

May 2005

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.